Search Results - "Ohno, Masuo"

Refine Results
  1. 1

    PERK as a hub of multiple pathogenic pathways leading to memory deficits and neurodegeneration in Alzheimer’s disease by Ohno, Masuo

    Published in Brain research bulletin (01-07-2018)
    “…•PERK, an eIF2α kinase, is overly activated in Alzheimer’s disease (AD).•Fine-tuning of eIF2α phosphorylation is essential for learning and memory in…”
    Get full text
    Journal Article
  2. 2

    Impairments in remote memory stabilization precede hippocampal synaptic and cognitive failures in 5XFAD Alzheimer mouse model by Kimura, Ryoichi, Ohno, Masuo

    Published in Neurobiology of disease (01-02-2009)
    “…Abstract Although animal models of Alzheimer's disease (AD) recapitulate β-amyloid-dependent hippocampal synaptic and cognitive dysfunctions, it is poorly…”
    Get full text
    Journal Article
  3. 3

    Accelerated long‐term forgetting is a BACE1 inhibitor‐reversible incipient cognitive phenotype in Alzheimer’s disease model mice by Ohno, Masuo

    Published in Neuropsychopharmacology reports (01-06-2021)
    “…Aim After the continued failure of β‐secretase (BACE1) inhibitor clinical trials in prodromal as well as mild‐to‐moderate Alzheimer's disease (AD), they are…”
    Get full text
    Journal Article
  4. 4

    Mitochondrial dysfunction and accumulation of the β-secretase-cleaved C-terminal fragment of APP in Alzheimer's disease transgenic mice by Devi, Latha, Ohno, Masuo

    Published in Neurobiology of disease (01-01-2012)
    “…Abstract Mitochondrial dysfunction is an early feature of Alzheimer's disease (AD) and may play an important role in the pathogenesis of disease. Emerging…”
    Get full text
    Journal Article
  5. 5

    Phospho-eIF2α level is important for determining abilities of BACE1 reduction to rescue cholinergic neurodegeneration and memory defects in 5XFAD mice by Devi, Latha, Ohno, Masuo

    Published in PloS one (23-09-2010)
    “…β-Site APP-cleaving enzyme 1 (BACE1) initiates amyloid-β (Aβ) generation and thus represents a prime therapeutic target in treating Alzheimer's disease (AD)…”
    Get full text
    Journal Article
  6. 6

    Deletion of the eIF2α Kinase GCN2 fails to rescue the memory decline associated with Alzheimer's disease by Devi, Latha, Ohno, Masuo

    Published in PloS one (11-10-2013)
    “…Emerging evidence suggests that dysregulated translation through phosphorylation of eukaryotic initiation factor-2α (eIF2α) may contribute to Alzheimer's…”
    Get full text
    Journal Article
  7. 7

    Partial reduction of BACE1 improves synaptic plasticity, recent and remote memories in Alzheimer's disease transgenic mice by Kimura, Ryoichi, Devi, Latha, Ohno, Masuo

    Published in Journal of neurochemistry (01-04-2010)
    “…J. Neurochem. (2010) 10.1111/j.1471-4159.2010.06608.x β-Site amyloid precursor protein cleaving enzyme 1 (BACE1) initiates amyloid-β (Aβ) generation that is…”
    Get full text
    Journal Article
  8. 8

    Mechanisms underlying insulin deficiency-induced acceleration of β-amyloidosis in a mouse model of Alzheimer's disease by Devi, Latha, Alldred, Melissa J, Ginsberg, Stephen D, Ohno, Masuo

    Published in PloS one (05-03-2012)
    “…Although evidence is accumulating that diabetes mellitus is an important risk factor for sporadic Alzheimer's disease (AD), the mechanisms by which defects in…”
    Get full text
    Journal Article
  9. 9

    A combination Alzheimer's therapy targeting BACE1 and neprilysin in 5XFAD transgenic mice by Devi, Latha, Ohno, Masuo

    Published in Molecular brain (25-03-2015)
    “…Accumulating evidence indicates that partial inhibition of β-site APP-cleaving enzyme 1 (BACE1), which initiates amyloid-β (Aβ) production, mitigates…”
    Get full text
    Journal Article
  10. 10
  11. 11

    BACE1 gene deletion prevents neuron loss and memory deficits in 5XFAD APP/PS1 transgenic mice by Ohno, Masuo, Cole, Sarah L, Yasvoina, Marina, Zhao, Jie, Citron, Martin, Berry, Robert, Disterhoft, John F, Vassar, Robert

    Published in Neurobiology of disease (01-04-2007)
    “…Abstract Evidence suggests that β-amyloid (Aβ) peptide triggers a pathogenic cascade leading to neuronal loss in Alzheimer’s disease (AD). However, the causal…”
    Get full text
    Journal Article
  12. 12

    Temporal memory deficits in Alzheimer's mouse models: rescue by genetic deletion of BACE1 by Ohno, Masuo, Chang, Lei, Tseng, Wilbur, Oakley, Holly, Citron, Martin, Klein, William L., Vassar, Robert, Disterhoft, John F.

    Published in The European journal of neuroscience (01-01-2006)
    “…Transgenic mouse models of Alzheimer's disease (AD) exhibit amyloid‐β (Aβ) accumulation and related cognitive impairments. Although deficits in…”
    Get full text
    Journal Article
  13. 13

    Sex- and brain region-specific acceleration of β-amyloidogenesis following behavioral stress in a mouse model of Alzheimer's disease by Devi, Latha, Alldred, Melissa J, Ginsberg, Stephen D, Ohno, Masuo

    Published in Molecular brain (08-11-2010)
    “…It is hypothesized that complex interactions between multiple environmental factors and genetic factors are implicated in sporadic Alzheimer's disease (AD);…”
    Get full text
    Journal Article
  14. 14

    Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1 by Silva, Alcino J, Costa, Rui M, Federov, Nikolai B, Kogan, Jeff H, Murphy, Geoffrey G, Stern, Joel, Ohno, Masuo, Kucherlapati, Raju, Jacks, Tyler

    Published in Nature (London) (31-01-2002)
    “…Neurofibromatosis type I (NF1) is one of the most common single-gene disorders that causes learning deficits in humans. Mice carrying a heterozygous null…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Alzheimer’s therapy targeting the β-secretase enzyme BACE1: Benefits and potential limitations from the perspective of animal model studies by Ohno, Masuo

    Published in Brain research bulletin (01-09-2016)
    “…Highlights • BACE1 knockout mice provide a useful model to test therapeutic β-secretase inhibition. • BACE1−/− mice show adverse phenotypes in line with a…”
    Get full text
    Journal Article
  17. 17

    Increased Neuronal Excitability, Synaptic Plasticity, and Learning in Aged Kvβ1.1 Knockout Mice by Murphy, Geoffrey G., Fedorov, Nikolai B., Giese, K.Peter, Ohno, Masuo, Friedman, Eugenia, Chen, Rachel, Silva, Alcino J.

    Published in Current biology (09-11-2004)
    “…Background: Advancing age is typically accompanied by deficits in learning and memory. These deficits occur independently of overt pathology and are often…”
    Get full text
    Journal Article
  18. 18

    PERK mediates eIF2α phosphorylation responsible for BACE1 elevation, CREB dysfunction and neurodegeneration in a mouse model of Alzheimer's disease by Devi, Latha, Ohno, Masuo

    Published in Neurobiology of aging (01-10-2014)
    “…Abstract Emerging evidence suggests that aberrant phosphorylation of eukaryotic initiation factor-2α (eIF2α) may induce synaptic failure and neurodegeneration…”
    Get full text
    Journal Article
  19. 19

    7,8-Dihydroxyflavone, a Small-Molecule TrkB Agonist, Reverses Memory Deficits and BACE1 Elevation in a Mouse Model of Alzheimer's Disease by Devi, Latha, Ohno, Masuo

    Published in Neuropsychopharmacology (New York, N.Y.) (01-01-2012)
    “…Increasing evidence suggests that reductions in brain-derived neurotrophic factor (BDNF) and its receptor tyrosine receptor kinase B (TrkB) may have a role in…”
    Get full text
    Journal Article
  20. 20

    Forebrain-specific knockout of B-raf kinase leads to deficits in hippocampal long-term potentiation, learning, and memory by Chen, Adele P., Ohno, Masuo, Giese, K. Peter, Kühn, Ralf, Chen, Rachel L., Silva, Alcino J.

    Published in Journal of neuroscience research (01-01-2006)
    “…Raf kinases are downstream effectors of Ras and upstream activators of the MEK‐ERK cascade. Ras and MEK‐ERK signaling play roles in learning and memory (L&M)…”
    Get full text
    Journal Article